Edith Jasny
Overview
Explore the profile of Edith Jasny including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
738
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Weinhold M, Eisenblatter M, Jasny E, Fehlings M, Finke A, Gayum H, et al.
PLoS One
. 2013 Jun;
8(6):e65934.
PMID: 23805193
Background: Bacterial vectors have been proposed as novel vaccine strategies to induce strong cellular immunity. Attenuated strains of Brucella abortus comprise promising vector candidates since they have the potential to...
12.
Eisenblatter M, Buchal A, Gayum H, Jasny E, Viveros P, Ulrichs T, et al.
Infect Immun
. 2012 Sep;
80(12):4195-202.
PMID: 22988018
Studying the interaction of dendritic cells (DCs) with bacteria controlled by T-cell-mediated immune responses may reveal novel adjuvants for the induction of cellular immunity. Murine studies and the observation that...
13.
Jasny E, Geer S, Frank I, Vagenas P, Aravantinou M, Salazar A, et al.
J Acquir Immune Defic Syndr
. 2012 Jul;
61(4):425-35.
PMID: 22820802
Background: The goal of antiretroviral therapy (ART) is to suppress virus replication to limit immune system damage. Some have proposed combining ART with immune therapies to boost antiviral immunity. For...
14.
Vagenas P, Aravantinou M, Williams V, Jasny E, Piatak Jr M, Lifson J, et al.
PLoS One
. 2010 Sep;
5(9):e12891.
PMID: 20877632
Background: HIV-infected individuals rely on antiretroviral therapy (ART) to control viral replication. Despite abundant demonstrable benefits, the multiple limitations of ART point to the potential advantages of therapeutic vaccination approaches...
15.
Crostarosa F, Aravantinou M, Akpogheneta O, Jasny E, Shaw A, Kenney J, et al.
PLoS One
. 2009 Dec;
4(11):e8060.
PMID: 20011586
Background: Herpes simplex virus type-2 (HSV-2) infection enhances the transmission and acquisition of human immunodeficiency virus (HIV). This occurs in symptomatic and asymptomatic stages of HSV-2 infection, suggesting that obvious...
16.
Stahl-Hennig C, Eisenblatter M, Jasny E, Rzehak T, Tenner-Racz K, Trumpfheller C, et al.
PLoS Pathog
. 2009 Apr;
5(4):e1000373.
PMID: 19360120
Toll-like receptor (TLR) ligands are being considered as adjuvants for the induction of antigen-specific immune responses, as in the design of vaccines. Polyriboinosinic-polyribocytoidylic acid (poly I:C), a synthetic double-stranded RNA...
17.
Jasny E, Eisenblatter M, Matz-Rensing K, Tenner-Racz K, Tenbusch M, Schrod A, et al.
J Immunol
. 2008 May;
180(10):6629-39.
PMID: 18453582
Experimental studies in monkeys on the basis of ex vivo-generated, reinjected dendritic cells (DCs) allow investigations of primate DC biology in vivo. To study in vitro and in vivo properties...
18.
Stahl-Hennig C, Eisenblatter M, Franz M, Stoiber H, Tenner-Racz K, Suh Y, et al.
Front Biosci
. 2006 Nov;
12:2107-23.
PMID: 17127448
Elucidating the mechanisms that protect monkeys previously immunized with attenuated SIV (SIVDeltanef) against challenge infection with pathogenic virus may reveal new strategies for the development of an effective HIV vaccine....
19.
Eisenblatter M, Stahl-Hennig C, Kuate S, Stolte N, Jasny E, Hahn H, et al.
Vaccine
. 2004 Aug;
22(25-26):3295-302.
PMID: 15308352
Granulocyte/macrophage-colony stimulating factor (GM-CSF) is a valuable adjuvant to enhance induction of cellular immune responses in rodents. Less information is available regarding its use as an adjuvant in primates or...